Dr William P Crutchlow, MD | |
7 E 20th St, Barnegat Light, NJ 08006-1496 | |
(973) 615-9398 | |
Not Available |
Full Name | Dr William P Crutchlow |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 7 E 20th St, Barnegat Light, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285069583 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 2226500 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr William P Crutchlow, MD 7 E 20th St, Po Box 683, Barnegat Light, NJ 08006-1496 Ph: (973) 615-9398 | Dr William P Crutchlow, MD 7 E 20th St, Barnegat Light, NJ 08006-1496 Ph: (973) 615-9398 |
News Archive
Natera, a leading innovator in prenatal genetic testing, and Echevarne, a leading clinical analysis laboratory in Spain, today announced the signing of a distribution agreement for Echevarne to offer Natera's non-invasive prenatal screening test, Panorama, through its facilities in Spain.
At the halfway mark, industry giant Anthem Blue Cross is holding on to a slim lead among health insurance providers with a 31% share of California's exchange market. The Covered California exchange released enrollment figures Tuesday for its 11 health plans from Oct. 1 to the end of December.
Isis Pharmaceuticals, Inc. announced today that it has earned a $3.0 million milestone payment from GlaxoSmithKline (GSK) related to the initiation of a natural history study, which will support the advancement of one of the alliance programs.
A targeted drug whose clinical testing was led by Richard Stone, MD, of Dana-Farber Cancer Institute, has become the first new treatment for newly diagnosed acute myeloid leukemia (AML) in more than 25 years.
› Verified 1 days ago